Axsome Therapeutics, Inc. (AXSM)
210.65
-3.63
(-1.69%)
USD |
NASDAQ |
Sep 18, 11:35
Axsome Therapeutics Price to Book Value : 132.25 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 17, 2026 | 134.53 |
| September 16, 2026 | 133.08 |
| September 15, 2026 | 128.12 |
| September 14, 2026 | 135.97 |
| September 11, 2026 | 138.59 |
| September 10, 2026 | 132.54 |
| September 09, 2026 | 132.24 |
| September 08, 2026 | 130.47 |
| September 04, 2026 | 129.76 |
| September 03, 2026 | 130.81 |
| September 02, 2026 | 131.79 |
| September 01, 2026 | 127.34 |
| August 31, 2026 | 124.64 |
| August 28, 2026 | 124.95 |
| August 27, 2026 | 129.50 |
| August 26, 2026 | 130.05 |
| August 25, 2026 | 129.00 |
| August 24, 2026 | 128.95 |
| August 21, 2026 | 130.44 |
| August 20, 2026 | 130.61 |
| August 19, 2026 | 136.99 |
| August 18, 2026 | 135.41 |
| August 17, 2026 | 135.78 |
| August 14, 2026 | 134.15 |
| August 13, 2026 | 134.15 |
| Date | Value |
|---|---|
| August 12, 2026 | 134.77 |
| August 11, 2026 | 135.46 |
| August 10, 2026 | 138.68 |
| August 07, 2026 | 133.56 |
| August 06, 2026 | 131.92 |
| August 05, 2026 | 133.63 |
| August 04, 2026 | 133.20 |
| August 03, 2026 | 132.50 |
| July 31, 2026 | 136.86 |
| July 30, 2026 | 147.31 |
| July 29, 2026 | 142.78 |
| July 28, 2026 | 147.04 |
| July 27, 2026 | 149.65 |
| July 24, 2026 | 151.30 |
| July 23, 2026 | 151.64 |
| July 22, 2026 | 150.44 |
| July 21, 2026 | 148.76 |
| July 20, 2026 | 139.15 |
| July 17, 2026 | 144.40 |
| July 16, 2026 | 148.82 |
| July 15, 2026 | 149.13 |
| July 14, 2026 | 147.70 |
| July 13, 2026 | 143.32 |
| July 10, 2026 | 146.78 |
| July 09, 2026 | 156.30 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 31.92 |
| Liquidia Corp. | 30.79 |
| Filana Therapeutics, Inc. | 0.5390 |
| CorMedix, Inc. | 1.296 |
| Eloxx Pharmaceuticals, Inc. | 1.598 |
Price to Book Value Related Metrics
| PS Ratio | 13.81 |
| Price | 210.65 |
| Earnings Yield | -1.78% |
| Market Cap | 11.02B |